Over the last two years, there’s been conflicting information in the news about GLP-1 medications and mental health. Some reports raised concerns about possible mood-related side effects, but others shared mental health benefits and broader therapeutic potential. Here’s what we know so far – and what still needs further research.
read more →
Dr. E gets personal in this month’s case study, sharing a recent experience he had of exercise-induced hypoglycemia with his hybrid closed-loop system. He offers four tips to avoid a blood sugar rollercoaster while working out with type 1 diabetes.
read more →
Ozempic and Mounjaro are similar in many ways, but there’s one key difference between the two. Learn how these blockbuster type 2 diabetes medications are changing the landscape of diabetes management, and find out why they aren’t yet approved for use in type 1.
read more →
2025 is shaping up to be a blockbuster year in diabetes care! From smart MDI systems to medications that pull triple duty, the future is looking smarter—and less invasive.
Here are several key advancements we expect to see in 2025.
When diabetes lives with you day-to-day like a stage five clinger, it can be easy to feel like advancements in care aren’t happening at a fast enough pace. But we’re here to tell you, things are happening! Here’s a short list of some of the progress we saw in 2024, including new pumps, new CGMs, and exciting research studies with promising results.
read more →
If You’re a Member of the Healthcare Community–You Can’t Miss Our Next CME!
Earn easy CME credits and improve patient outcomes—all at your own pace.
